Under New CEO, Glaxo Will Leverage OTCs In Emerging Markets

 
• By Malcolm Spicer

GlaxoSmithKline will seed its growth in emerging markets with OTC drugs and other nonprescription products, according to Chris Viehbacher, the firm's North American Pharmaceuticals division president

More from Archive

More from Pink Sheet